Product NDC: | 0781-3059 |
Proprietary Name: | Digoxin |
Non Proprietary Name: | Digoxin |
Active Ingredient(s): | 250 ug/mL & nbsp; Digoxin |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-3059 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040481 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030821 |
Package NDC: | 0781-3059-95 |
Package Description: | 10 AMPULE in 1 CARTON (0781-3059-95) > 2 mL in 1 AMPULE (0781-3059-72) |
NDC Code | 0781-3059-95 |
Proprietary Name | Digoxin |
Package Description | 10 AMPULE in 1 CARTON (0781-3059-95) > 2 mL in 1 AMPULE (0781-3059-72) |
Product NDC | 0781-3059 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Digoxin |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL |
Start Marketing Date | 20030821 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | DIGOXIN |
Strength Number | 250 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |